Skip to main content

Search

Study Finds No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
Eugene Washington To Step Down From Duke Health in 2023
New Pan-Coronavirus Vaccine Passes Key Experiments, Demonstrates Protection
Industry payments to physicians and advanced practice clinicians compared
Comparative Study of Two Heart Failure Drugs Finds No Difference in Outcomes
Largest Randomized Trial Evaluates Steroids for Infant Heart Surgery
Chest Pain Patients Benefit from Precision Diagnostic Testing Approach
Mechanism Identified for Drug Resistance in Glioblastoma Brain Tumors
Protected From a Form of Cell Death, Women are More Resilient to Kidney Disease
Duke Children’s Hospital Remains #1 in North Carolina for Pediatric Care
Newly Identified Aspect of Cell Death May Impact the Future of Fighting Diseases
Duke Researcher Part of Prestigious Grant to Explore the Origins of Cancer
DUHS Statement On Community Assistance and Investment in Response to State Treasurer’s Report
Duke Health Statement on SCOTUS Abortion Ruling
Duke Awarded Federal Grant to Build Structural Models of HIV
Fish Oil Appears to Ease Post-Operative Delirium in Pre-Clinical Studies
Monoclonal Antibody Treatment Reduced Deaths in Hospitalized COVID Patients
Racing for ALS Raises Money for Lou Gehrig's Disease Research
Study Finds No Benefit to Taking Fluticasone Furoate for COVID-19 Symptoms
Duke-UNC Project Wins 3rd Place in American Heart Association Heart Failure Data Challenge